AstraZeneca’s experimental drug baxdrostat cut systolic BP by nearly 10 mmHg in a late-stage trial, offering hope to patients at a high risk of heart attacks, among others.
If included in National List of Essential Medicines (NLEM), the fixed-dose combinations (FDCs) to rein in hypertension can be made available free of cost to patients through government hospitals.
Report, published in JAMA Internal Medicine Monday, says researchers 'found no difference' in BP reduction between group using traditional BP instruments & the one with smart devices.
The National Family Health Survey 5 data revealed that India's cancer screening coverage also remains poor, with only 0.6% undergoing breast examination and 0.7% taking oral cavity test.
India's bakery market is expected to grow 8.5% to reach more than $12 billion by 2026. But evidence is also building up against refined foods as producing more harm than good.
The new set of benchmarks have been based on local food environments and target processed and packaged foods in an effort to lower risks of blood pressure and cardiovascular disease.
Researchers from IIT Delhi, Brookings Institution and Ashoka University find reducing disease burden associated with hypertension can help save $1.73 to 2.24 billion over 5 years.
Study by ICMR and WHO scientists finds that a good number of patients registered with India Hypertension Control Initiative were successful in controlling their blood pressure.
A poor Muslim man from Kurnool, selling khoya buns during the Medaram Jatara in Telangana, was harassed by some YouTubers and surrounded by a mob over allegations of 'food jihad'.
This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they’d seen marginal interest. The starkest example is India & Europe.
COMMENTS